TABLE 2.
Species | No. of isolates tested | Cumulative % of isolates susceptible at MIC (μg/ml)b of:
|
|||||||
---|---|---|---|---|---|---|---|---|---|
0.03 | 0.06 | 0.12 | 0.25 | 0.5 | 1 | 2 | 4 | ||
C. albicans | 47 | 0 | 0 | 30 | 66 | 74 | 96 | 98 | 100 |
C. glabrata | 121 | 1 | 45 | 68 | 82 | 95 | 100 | ||
C. krusei | 171 | 38 | 38 | 38 | 39 | 47 | 88 | 99 | |
Candida spp.c | 12 | 25 | 25 | 42 | 58 | 67 | 67 | 92 | 100 |
All species | 351 | 20 | 35 | 47 | 58 | 68 | 92 | 99 | 100 |
Fluconazole resistance was determined by NCCLS M27-A2 broth microdilution and fluconazole interpretive criteria (resistance MIC, ≥64 μg/ml).
Caspofungin MICs were determined by the NCCLS M27-A2 broth microdilution method.
C. tropicalis (three isolates), C. guilliermondii (three isolates), C. parapsilosis (four isolates), C. lusitaniae (one isolate), and C. lipolytica (one isolate).